Cited by 128Phytochemicals and Medicinal PlantsMedicinal Plants and NeuroprotectionPharmacological Effects of Medicinal Plants

Effects of Ashwagandha (Roots of Withania somnifera) on Neurodegenerative Diseases

Open access
Kuboyama, Tomoharu, Tohda, Chihiro, Komatsu, Katsuko·2014·Biological and Pharmaceutical Bulletin

Abstract

Neurodegenerative diseases commonly induce irreversible destruction of central nervous system (CNS) neuronal networks, resulting in permanent functional impairments. Effective medications against neurodegenerative diseases are currently lacking. Ashwagandha (roots of Withania somnifera Dunal) is used in traditional Indian medicine (Ayurveda) for general debility, consumption, nervous exhaustion, insomnia, and loss of memory. In this review, we summarize various effects and mechanisms of Ashwagandha extracts and related compounds on in vitro and in vivo models of neurodegenerative diseases such as Alzheimer's disease and spinal cord injury.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1248/bpb.b14-00022

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 10

  1. Kanaan NM, Pigino GF, Brady ST, Lazarov O, Binder LI, Morfini GA. Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system. Exp. Neurol., 246, 44-53 (2013). · DOI
  2. Silver J, Miller JH. Regeneration beyond the glial scar. Nat. Rev. Neurosci., 5, 146-156 (2004). · DOI
  3. Imagama S, Sakamoto K, Tauchi R, Shinjo R, Ohgomori T, Ito Z, Zhang H, Nishida Y, Asami N, Takeshita S, Sugiura N, Watanabe H, Yamashita T, Ishiguro N, Matsuyama Y, Kadomatsu K. Keratan sulfate restricts neural plasticity after spinal cord injury. J. Neuro- sci., 31, 17091-17102 (2011). · DOI
  4. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci., 7, 617-627 (2006). · DOI
  5. Kulkarni SK, Dhir A. Withania somnifera: an Indian ginseng. Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 1093-1105 (2008). · DOI · Paper page
  6. Kuboyama T, Tohda C, Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate A beta(25-35)-induced neurodegen- eration. Eur. J. Neurosci., 23, 1417-1426 (2006). · DOI · Paper page
  7. Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, Khanna P, Jain SC, Thakur SS, Ravindranath V. Withania somnifera re- verses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc. Natl. Acad. Sci. · DOI · Paper page
  8. Teshigawara K, Kuboyama T, Shigyo M, Nagata A, Sugimoto K, Matsuya Y, Tohda C. A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte- secreted vimentin. Br. J. Pharmacol., 168, 903-919 (2013). · DOI
  9. Vyas AR, Singh SV. Molecular targets and mechanisms of cancer prevention and treatment by withaferin A, a naturally occurring steroidal lactone. AAPS J., 16, 1-10 (2014). · DOI
  10. Kumar P, Kumar A. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced be- havioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J. Med. Food, 12, 591-600 (2009). · DOI · Paper page

Cited by

Sorted by citations

Authors
Kuboyama, T., Tohda, C., & Komatsu, K.
Affiliations
University of Toyama (JP)
Venue
Biological and Pharmaceutical Bulletin
Published
2014
Volume
37
Issue
6
Pages
892-897
ISSN
  • 0918-6158 (ISSN-L)
  • 1347-5215
OpenAlex
W2129664426
Cited by
127
References
58
Citations by year
2026: 5 · 2025: 6 · 2024: 12 · 2023: 20 · 2022: 16 · 2021: 17 · 2020: 14 · 2019: 10 · 2018: 5 · 2017: 12 · 2016: 4 · 2015: 6
FWCI
2.02
Type
journal article
Language
en
Open access
Locations
  • Biological and Pharmaceutical Bulletin (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Institute of Natural Medicine, University of Toyama
  • Japan Society for the Promotion of Science (23700376, 23500439)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Pharmacology › Pharmacological Effects of Medicinal Plants
Keywords
Withania somnifera, neurodegenerative diseases, Alzheimer's disease, spinal cord injury, Ayurveda, neuroprotective activity, traditional medicine, plant extracts
MeSH terms
Alzheimer Disease, Humans, Medicine, Ayurvedic, Plant Extracts, Spinal Cord Injuries, Molecular Structure, Plant Roots, Neuroprotective Agents, Neurodegenerative Diseases, Withania

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review